26164 | TEst 4 | testgt | 10/12/2013 8:02:54 AM |
26163 | testdtt | testgt | 10/12/2013 7:06:08 AM |
26162 | test 13 | testgt | 10/12/2013 7:02:06 AM |
26161 | test 111 | testgt | 10/12/2013 7:01:16 AM |
26160 | hello test | itest | 10/12/2013 3:48:16 AM |
26159 | Test 1 | spdpro | 10/11/2013 10:02:43 PM |
26158 | testing post.. | muditshukla1 | 10/11/2013 9:38:13 AM |
26157 | testing for signature | mudit | 10/11/2013 7:21:08 AM |
26155 | testing | itest | 10/11/2013 2:32:41 AM |
26154 | ok3 | testuser | 10/10/2013 10:40:43 PM |
26153 | irp | testuser | 10/10/2013 10:11:05 PM |
26152 | hello | testuser | 10/10/2013 10:10:27 PM |
26151 | hello | testuser | 10/10/2013 10:10:08 PM |
26150 | testing | itest | 10/10/2013 10:22:42 AM |
26149 | Helloo test | itest | 10/10/2013 5:24:42 AM |
26148 | Helloo test | itest | 10/10/2013 5:24:35 AM |
26147 | Helloo test | itest | 10/10/2013 5:24:28 AM |
26146 | hi | testname | 10/09/2013 8:24:39 PM |
26145 | $GOOG DD Notes ~ http://www.ddnotesmaker.com/GOOG | testuser | 10/09/2013 6:33:33 PM |
26144 | itest public profile | saurabh | 10/09/2013 7:47:14 AM |
26143 | testing only | saurabh | 10/09/2013 7:38:36 AM |
26142 | testings | saurabh | 10/09/2013 7:29:20 AM |
26141 | testtt | saurabh | 10/09/2013 7:28:12 AM |
26140 | pppp | saurabh | 10/09/2013 7:06:49 AM |
26139 | test suarbah | saurabh | 10/09/2013 7:00:58 AM |
26138 | itesy publuc | saurabh | 10/09/2013 6:52:20 AM |
26137 | yest | itest | 10/09/2013 6:49:43 AM |
26136 | r public | testgt | 10/09/2013 5:00:47 AM |
26135 | test 11 | testgt | 10/09/2013 4:57:43 AM |
26134 | hii test public reply.. | testgt | 10/09/2013 3:53:18 AM |
26133 | hiii my post | testgt | 10/09/2013 3:52:38 AM |
26132 | test free 11 | testgt | 10/09/2013 3:43:42 AM |
26131 | mmmmmmmmmm... | Pipa | 10/08/2013 3:38:49 PM |
26130 | http://www.youtube.com/watch?feature=player_embed | Pipa | 10/08/2013 3:38:07 PM |
26129 | Test | Pipa | 10/08/2013 10:34:24 AM |
26127 | test | saurabh | 10/07/2013 6:06:54 AM |
26126 | testing | saurabh | 10/07/2013 3:23:15 AM |
26125 | test test1 test2 test3 | saurabh | 10/07/2013 3:18:00 AM |
26124 | test | itest | 10/07/2013 1:03:00 AM |
26123 | testtt | testuser | 10/06/2013 2:38:08 PM |
26122 | testing | testuser | 10/06/2013 2:27:57 PM |
26121 | just test | itest | 10/05/2013 8:17:36 AM |
26120 | test133 | itest | 10/05/2013 8:16:23 AM |
26119 | tedy bear | itest | 10/05/2013 8:13:52 AM |
26118 | testting only | itest | 10/05/2013 8:11:41 AM |
26117 | testing public reply | itest | 10/05/2013 7:50:42 AM |
26116 | elo hello g | saurabh | 10/04/2013 11:57:03 AM |
26115 | dsfasdfasdfasdf | saurabh | 10/04/2013 11:56:39 AM |
26114 | test post | itest | 10/04/2013 9:48:41 AM |
26113 | test | itest | 10/04/2013 9:47:59 AM |
Recent Articles
- Reima Rytsölä Steps Up as New CEO of Kojamo plc
- Sampo plc's Recent Share Buyback Insights and Impacts
- Strategic Alliance Between Dev4All and Pharmaseed Enhances R&D
- Rémy Cointreau Reveals Availability of Financial Report Online
- Getlink SE Faces Delays in ElecLink Operations Recovery
- Shenzhen's Transformative Influence on Global Branding and Quality
- Jiangsu's Transformation: Merging Rich History with Innovation
- Hexagon Purus ASA Reports Record Q3 Growth and Future Plans
- CTP Delivers State-of-the-Art Logistics Facility to Tesco
- Galderma's Nemolizumab Shows Promising Results for Itch Relief
- Explore Tokyo Psychodemic: An Immersive Gaming Experience
- Neos Corporation Unveils Enhanced Crayon Shin-chan App for iOS
- CoinEx Charity's Starlink Initiative Transforms Connectivity
- Zai Lab Boosts Patient Access to AUGTYRO for Lung Cancer
- Recursive Teams Up with Saudi Arabia for AI-Powered TB Solutions
- Akeso's Cadonilimab and Ivonescimab Added to National Drug List
- TeamT5 Earns Prestigious Recognitions in Cybersecurity Innovation
- Innovent Biologics Adds SINTBILO and Olverembatinib to NRDL
- Genesis Lifestyle Medicine Recognized for Stellar Leadership Achievement
- Genesis Lifestyle Medicine Earns Certified Amazing Workplace Honor
- Bridging Cultures: China and Europe's River Dialogues
- The Surge in Population Health Management: A $663.75 Billion Future
- Prime Mining Releases New Technical Report on Los Reyes Project
- Investigation Announced for Symbotic Inc. Shareholders
- Monument Mining Limited Reports Positive Q1 FY 2025 Results
- Strategic Alliance Between Sumitomo and Rikkeisoft Ignites Growth
- Innovative Approaches to Combat the Fall Armyworm Crisis
- Exro Technologies Faces Potential Class Action Suit
- BioArctic's Leqembi®: A New Hope for Alzheimer's Patients
- BioArctic Partners with Eisai for Leqembi Launch in Asia
- Rakovina Therapeutics Unveils New Financial Strategy for Growth
- Nonwoven Filtration Market Expected to Hit $8.4 Billion by 2028
- AIP Realty Trust Reports Q3 Financial Progress and Future Growth
- Weave Living and KKR Form Joint Venture to Enhance Japan's Housing Market
- Celsius Holdings Faces Legal Challenges—What Investors Should Know
- Lomiko Metals Secures Funding for La Loutre Graphite Project
- U.S. Gold Corp. Launches Significant $10.2 Million Offering
- Key Insights into the Growth of the Medical Nonwoven Market
- Exploring the Growth of the Portable Power Station Market
- Investors Alert: Class Action Update on Edwards Lifesciences
- Casio Unveils Iconic DW-5000R, A Nod to G-SHOCK Heritage
- Casio Unveils New DW-5000R, Reviving G-SHOCK's Legacy
- American Lithium's Annual Meeting Highlights and Future Plans
- Rentokil Initial PLC Faces Class Action Claims - Key Insights
- Significant Jury Victory for Guardant Health Against Natera
- Robbins LLP Highlights Class Action Opportunities for AILE Investors
- Legal Update: Dentsply Sirona Inc. Class Action Notification
- Exploring Growth within the Animal Feed Additives Industry
- Women’s Watch Market Set for Significant Growth by 2031
- Eisai and Biogen Launch LEQEMBI for Alzheimer's in New Markets